Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 -- Titan Pharmaceuticals, Inc. today announced that by letter dated January 24, 2024, the Company was notified by The Nasdaq Stock Market LLC that the...

Related Keywords

Kate Beebe Devarney ,Securities Exchange ,Globenewswire Inc ,Titan Pharmaceuticals Inc ,Nasdaq ,Nasdaq Stock Market ,Titan Pharmaceuticals ,Exchange Commission ,Nasdaq Capital ,San Francisco ,Securities Act ,Securities Exchange Act ,Annual Report ,Investor Contacts ,Beebe Devarney ,Chief Operating ,